ProCure selects IBA one more time as supplier for a Proton Therapy system
IBA Molecular presents an all-new version of its Synthera® at SNM’10
Read it in : English
IBA Molecular Addresses Nuclear Medicine Industry's Molybdenum Shortage with Solutions
Read it in : English
REDECTANE® meets both endpoints specificity and sensitivity with superiority over CT in its pivotal Phase III trial
Read it in : English
CE Certification Granted for IBA’s 2nd Generation Pencil Beam Scanning Proton Treatment System
Read it in : English
Dasheng and IBA have entered an exclusive agreement for the distribution of the Dasheng E-beam Accelerators by IBA outside of China.
Read it in : English
New Proton Therapy Order: PROCURE contracts once more with IBA for its new Center in New Jersey